Bausch Health Cos Inc. (NYSE:BHC) Director John Paulson Acquires 3,564,059 Shares

Bausch Health Cos Inc. (NYSE:BHC) Director John Paulson bought 3,564,059 shares of Bausch Health Cos stock in a transaction that occurred on Friday, June 13th. The stock was purchased at an average price of $5.94 per share, for a total transaction of $21,170,510.46. Following the acquisition, the director now directly owns 32,791,702 shares of the company’s stock, valued at $194,782,709.88. The trade was a 12.19% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

John Paulson also recently made the following trade(s):

• On Thursday, June 12th, John Paulson acquired 1,005,376 shares of Bausch Health Cos stock. The stock was purchased at an average cost of $5.47 per share, for a total transaction of $5,499,406.72.
• On Wednesday, June 11th, John Paulson acquired 1,029,098 shares of Bausch Health Cos stock. The stock was purchased at an average cost of $5.24 per share, for a total transaction of $5,392,473.52.
• On Tuesday, June 10th, John Paulson acquired 754,134 shares of Bausch Health Cos stock. The stock was purchased at an average cost of $5.05 per share, for a total transaction of $3,808,376.70.

Bausch Health Cos Price Performance

Shares of BHC opened at $5.73 on Wednesday. The stock’s 50-day moving average is $4.88 and its two-hundred day moving average is $6.38. The stock has a market cap of $2.12 billion, a PE ratio of -52.11 and a beta of 0.28. Bausch Health Cos Inc. has a 12 month low of $3.96 and a 12 month high of $9.85.

Hedge Funds Weigh In On Bausch Health Cos

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. SBI Securities Co. Ltd. lifted its holdings in Bausch Health Cos by 244.2% in the 1st quarter. SBI Securities Co. Ltd. now owns 4,230 shares of the company’s stock worth $27,000 after buying an additional 3,001 shares in the last quarter. Cary Street Partners Financial LLC acquired a new position in shares of Bausch Health Cos in the first quarter worth about $27,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Bausch Health Cos in the first quarter worth about $27,000. Mountain Hill Investment Partners Corp. acquired a new position in shares of Bausch Health Cos in the fourth quarter worth about $56,000. Finally, Wealthquest Corp acquired a new position in shares of Bausch Health Cos in the first quarter worth about $58,000. 78.65% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

BHC has been the topic of a number of recent research reports. Wall Street Zen cut shares of Bausch Health Cos from a “buy” rating to a “hold” rating in a research report on Saturday, May 10th. Royal Bank Of Canada lifted their target price on shares of Bausch Health Cos from $8.50 to $10.00 and gave the company a “sector perform” rating in a report on Friday, May 2nd. One analyst has rated the stock with a sell rating and seven have given a hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $7.42.

Bausch Health Cos Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.